Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$2.60M
9.24K shares
What this filing means
CAUSEY CHRISTOPHER plans to sell 9.24K shares of UNITED THERAPEUTICS CORP valued at approximately $2.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/18/2024ACC: 0001950047-24-004894
Director
Since Mar 2026
9.24K
Shares to sell
$2.60M
Approx. market value
3K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/18/2024
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/18/2024 | Stock Option Exercise Cash | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2K
Market value
$563.1K
6/13/2024
—Completed
Units to sell
2K
Market value
$545.6K
5/15/2024
—Completed
Units to sell
2.24K
Market value
$582.2K
5/3/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
3K
Market value
$912.5K
6/18/2024
Total
Units
9.24K
Value
$2.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/13/2024 | 2K | $563.1K | — | Completed |
5/15/2024 | 2K | $545.6K | — | Completed |
5/3/2024 | 2.24K | $582.2K | — | Completed |
| Planned — Approximate Date | ||||
6/18/2024 | 3K | $912.5K | NASDAQ | Planned |
| Total | 9.24K | $2.60M | ||